Position in ABCL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,845,746
-$11,245,983 QoQ
Shares Held
235,127
-93.7% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 150 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABCL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. ABCL ranks #229 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in ABCL
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,845,746 | 235,127 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $13,091,729 | 3,751,212 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $14,858,138 | 4,344,485 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $1,258,591 | 250,217 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $750,226 | 218,725 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $192,857 | 86,483 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $878,452 | 299,813 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $534,838 | 205,707 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $283,473 | 95,768 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $935,114 | 206,427 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,433,086 | 601,241 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $1,192,761 | 259,296 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $2,714,989 | 420,277 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $2,649,148 | 351,346 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $4,709,193 | 464,876 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $3,968,035 | 401,217 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $2,497,286 | 234,487 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $1,099,068 | 112,725 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,936,920 | 135,449 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $375,649 | 18,745 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $683,210 | 31,055 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $941,778 | 27,732 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||